Information for Retatrutide
Page information·measured at build time
Technical and provenance information about Retatrutide. All figures on this page are measured from the emitted page rather than declared.
Basic information
| Display title | Retatrutide |
|---|---|
| Default sort key | Retatrutide |
| Namespace | Article (main) |
| Page kind | Compound |
| Page length (source, bytes) | 7,421 |
| Rendered word count | 911 |
| Internal wiki links on the page | 26 |
| Defined citations | 4 |
| Top-level sections | 4 |
| Subsections | 0 |
| Tables | 1 |
| Figures | 0 |
| Infobox | Yes — compound |
| Maintenance banners | medical, update |
| Indexing by robots | Allowed |
Edit history
| Page creator | GastroparesisGwen |
|---|---|
| Date of page creation | 1 July 2024 |
| Latest editor | SPPS_Sorrel |
| Date of latest edit | 18 July 2026 |
| Total number of edits | 43 |
| Total number of distinct authors | 31 |
| Minor edits | 16 |
| Automated (bot) edits | 4 |
| Recent number of edits (last 90 days) | 4 |
| Talk page posts | 8 |
Principal authors
| Editor | Edits | Share | Declared focus |
|---|---|---|---|
| OralSemaOswin | 3 | 7.0% | GLP-1 receptor agonists and related compounds |
| Chromatokid | 3 | 7.0% | analytical chemistry and chromatography |
| MazdutideMads | 3 | 7.0% | GLP-1 receptor agonists and related compounds |
| SemaglutideSasha | 3 | 7.0% | GLP-1 receptor agonists and related compounds |
| DulaglutideDug | 2 | 4.7% | GLP-1 receptor agonists and related compounds |
| LiraLotte | 2 | 4.7% | GLP-1 receptor agonists and related compounds |
| CagriCass | 2 | 4.7% | GLP-1 receptor agonists and related compounds |
| TirzTaxonomist | 2 | 4.7% | GLP-1 receptor agonists and related compounds |
| GastroparesisGwen | 1 | 2.3% | adverse effects and clinical safety |
| FmocFrancis | 1 | 2.3% | peptide synthesis and supply chain |
| EscalationEira | 1 | 2.3% | dosing, titration and injection practice |
| GMP_Gita | 1 | 2.3% | compounding law and drug regulation |
Category membership
- Category:Dual and triple agonists — 5 member pages
- Category:Peptide drugs — 17 member pages
- Category:Articles describing unapproved compounds — 21 member pages
- Category:Articles needing updates — 6 member pages
- Category:Articles describing unapproved compounds (maintenance)
- Category:Articles needing updates (maintenance)